Juva Life, Inc. (TSE:JUVA) has released an update.
Claim 70% Off TipRanks Premium
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
Juva Life Inc., a life science company specializing in pharmaceutical research and cannabis production, has announced a delay in filing their annual financial statements for 2023 due to auditing complexities stemming from a recent reorganization. The company has received a management cease trade order against its CEO and CFO until the filings are completed, which is expected by June 28, 2024. In the interim, Juva Life will provide bi-weekly updates in compliance with regulatory guidelines.
For further insights into TSE:JUVA stock, check out TipRanks’ Stock Analysis page.